Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Gritstone Oncology, Inc. (GRTS)
Sector: Healthcare; Industry: Biotechnology

Gritstone Oncology, Inc., an immuno-oncology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-09-08 Jones Erin nan Sell 2,000 $11.37 $22,748 Yes
2021-11-01 Jones Erin nan Sell 1,000 $11.14 $11,140 Yes
2021-10-04 Jones Erin nan Sell 2,000 $10.70 $21,390 Yes
2021-05-27 Rousseau Raphael nan Sell 2,900 $9.00 $26,112 Yes
2021-01-20 Rousseau Raphael nan Sell 30,000 $20.04 $601,269 Yes
2021-01-19 Yelensky Roman nan Sell 10,000 $22.10 $221,029 No
2020-12-30 Woiwode Thomas Director Buy 1,347,709 $3.71 $5,000,000 No
2019-08-21 Rousseau Raphael See Remarks Sell 10,000 $10.76 $107,631 Yes
2018-09-28 Simon Nicholas 10%-Owner, Director Buy 333,333 $15.00 $4,999,995 Yes
2018-09-28 Clarus Lifesciences III, L.P. 10%-Owner Buy 333,333 $15.00 $4,999,995 Yes

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.